Fagron NV (id:355 FAGR)
18.30 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/3/2024 6:13:04 PM)
Exchange closed, opens in 14 hours 46 minutes
About Fagron NV
Market Capitalization 1.37B
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
| Headquarters (address) |
Venecoweg 20A Nazareth 9810 Belgium |
| Phone | 32 8 001 28 80 |
| Website | https://www.fagron.com |
| Employees | 3,647 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | FAGR |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 16.50 - 20.05 |
| Market Capitalization | 1.37B |
| Dividend yield forward | 6.41 % |
| Dividend yield forward Belgium (ID:14, base:74) | 17.69 % |
| P/E trailing | 17.50 |
| P/E forward | 14.18 |
| Price/Sale | 1.67 |
| Price/Book | 2.89 |
| Beta | 0.257 |
| EPS | 1.07 |
| EPS Belgium (ID:14, base:78) | 4.66 |
Dividend growth streak
Fagron NV has raised their dividend 3.00 years in a row. This is below the 4.483360 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Fagron NV has raised their dividend 6.41 years in a row. This is below the 41868.092400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Fagron NV has raised their dividend 46.20 years in a row. This is above the 24.016700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Fagron NV has raised their dividend 20.11 years in a row. This is above the 12.547200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Fagron NV has raised their dividend 28.04 years in a row. This is below the 147.720300 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Fagron NV years needed to self fund. This is below the 62.481481 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Fagron NV has raised their dividend 3.00 years in a row. This is below the 4.483360 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Fagron NV has raised their dividend 6.41 years in a row. This is below the 41868.092400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Fagron NV has raised their dividend 46.20 years in a row. This is above the 24.016700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Fagron NV has raised their dividend 20.11 years in a row. This is above the 12.547200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Fagron NV has raised their dividend 28.04 years in a row. This is below the 147.720300 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Fagron NV years needed to self fund. This is below the 62.481481 year average in the 'Drug Manufacturers Specialty & Generic' industry